Unraveling the Crosstalk Between Lipids and NADPH Oxidases in Diabetic Kidney Disease

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2023 May 27

PMID 37242602

Authors

Rachel Njeim

Sahar Alkhansa

Alessia Fornoni

Affiliations

Soon will be listed here.

Abstract

Diabetic kidney disease (DKD) is a serious complication of diabetes mellitus and a leading cause of end-stage renal disease. Abnormal lipid metabolism and intrarenal accumulation of lipids have been shown to be strongly correlated with the development and progression of diabetic kidney disease (DKD). Cholesterol, phospholipids, triglycerides, fatty acids, and sphingolipids are among the lipids that are altered in DKD, and their renal accumulation has been linked to the pathogenesis of the disease. In addition, NADPH oxidase-induced production of reactive oxygen species (ROS) plays a critical role in the development of DKD. Several types of lipids have been found to be tightly linked to NADPH oxidase-induced ROS production. This review aims to explore the interplay between lipids and NADPH oxidases in order to provide new insights into the pathogenesis of DKD and identify more effective targeted therapies for the disease.

Citing Articles

Genetic association analysis of lipid-lowering drug target genes in chronic kidney disease.

Zhang Y, Ou G, Peng L, Pan J, Zhang S, Shi J Front Endocrinol (Lausanne). 2025; 15:1434145.

PMID: 39877840 PMC: 11772207. DOI: 10.3389/fendo.2024.1434145.

Global research hotspots and trends in oxidative stress-related diabetic nephropathy: a bibliometric study.

Wang X, Wu Z, He T, Chen X, Jin X, Zuo C Front Endocrinol (Lausanne). 2025; 15:1451954.

PMID: 39866738 PMC: 11757133. DOI: 10.3389/fendo.2024.1451954.

Molecular Links and Clinical Effects of Inflammation and Metabolic Background on Ischemic Stroke: An Update Review.

Pacinella G, Ciaccio A, Tuttolomondo A J Clin Med. 2025; 13(24.

PMID: 39768436 PMC: 11679813. DOI: 10.3390/jcm13247515.

The ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol is associated with diabetic kidney disease: A cross-sectional study.

Zhang L, Fan D, Zhu T, Geng L, Gan L, Ou S PLoS One. 2024; 19(11):e0311620.

PMID: 39602386 PMC: 11602080. DOI: 10.1371/journal.pone.0311620.

Lipid homeostasis in diabetic kidney disease.

Wang Y, Liu T, Wu Y, Wang L, Ding S, Hou B Int J Biol Sci. 2024; 20(10):3710-3724.

PMID: 39113692 PMC: 11302873. DOI: 10.7150/ijbs.95216.

References

Qiu Y, Tang L . Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy. Pharmacol Res. 2016; 114:251-264. DOI: 10.1016/j.phrs.2016.11.004. View

Konarzewski M, Szolkiewicz M, Sucajtys-Szulc E, Blaszak J, Lizakowski S, Swierczynski J . Elevated circulating PCSK-9 concentration in renal failure patients is corrected by renal replacement therapy. Am J Nephrol. 2014; 40(2):157-63. DOI: 10.1159/000365935. View

Williams K, Schalinske K . Homocysteine metabolism and its relation to health and disease. Biofactors. 2010; 36(1):19-24. DOI: 10.1002/biof.71. View

Zhang Y, Ma K, Liu J, Wu Y, Hu Z, Liu L . Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy. Acta Diabetol. 2015; 52(6):1045-56. DOI: 10.1007/s00592-015-0753-9. View

Maki T, Maeda Y, Sonoda N, Makimura H, Kimura S, Maeno S . Renoprotective effect of a novel selective PPARα modulator K-877 in db/db mice: A role of diacylglycerol-protein kinase C-NAD(P)H oxidase pathway. Metabolism. 2017; 71:33-45. DOI: 10.1016/j.metabol.2017.02.013. View

Ren S, Babelova A, Moreth K, Xin C, Eberhardt W, Doller A . Transforming growth factor-beta2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-beta2 by impeding CTGF expression. Kidney Int. 2009; 76(8):857-67. DOI: 10.1038/ki.2009.297. View

Yoo T, Pedigo C, Guzman J, Correa-Medina M, Wei C, Villarreal R . Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease. J Am Soc Nephrol. 2014; 26(1):133-47. PMC: 4279736. DOI: 10.1681/ASN.2013111213. View

Eid A, Gorin Y, Fagg B, Maalouf R, Barnes J, Block K . Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes. 2009; 58(5):1201-11. PMC: 2671039. DOI: 10.2337/db08-1536. View

Boini K, Zhang C, Xia M, Han W, Brimson C, Poklis J . Visfatin-induced lipid raft redox signaling platforms and dysfunction in glomerular endothelial cells. Biochim Biophys Acta. 2010; 1801(12):1294-304. PMC: 2963068. DOI: 10.1016/j.bbalip.2010.09.001. View

10.

Fobker M, Voss R, Reinecke H, Crone C, Assmann G, Walter M . Accumulation of cardiolipin and lysocardiolipin in fibroblasts from Tangier disease subjects. FEBS Lett. 2001; 500(3):157-62. DOI: 10.1016/s0014-5793(01)02578-9. View

11.

Inoguchi T, Sonta T, Tsubouchi H, Etoh T, Kakimoto M, Sonoda N . Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J Am Soc Nephrol. 2003; 14(8 Suppl 3):S227-32. DOI: 10.1097/01.asn.0000077407.90309.65. View

12.

Bhunia A, Han H, Snowden A, Chatterjee S . Redox-regulated signaling by lactosylceramide in the proliferation of human aortic smooth muscle cells. J Biol Chem. 1997; 272(25):15642-9. DOI: 10.1074/jbc.272.25.15642. View

13.

Wicinski M, Zak J, Malinowski B, Popek G, Grzesk G . PCSK9 signaling pathways and their potential importance in clinical practice. EPMA J. 2017; 8(4):391-402. PMC: 5700013. DOI: 10.1007/s13167-017-0106-6. View

14.

Yaribeygi H, Mohammadi M, Rezaee R, Sahebkar A . Fenofibrate improves renal function by amelioration of NOX-4, IL-18, and p53 expression in an experimental model of diabetic nephropathy. J Cell Biochem. 2018; 119(9):7458-7469. DOI: 10.1002/jcb.27055. View

15.

Ferrans V, Fredrickson D . The pathology of Tangier disease. A light and electron microscopic study. Am J Pathol. 1975; 78(1):101-58. PMC: 1915033. View

16.

Yi F, Zhang A, Li N, Muh R, Fillet M, Renert A . Inhibition of ceramide-redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats. Kidney Int. 2006; 70(1):88-96. DOI: 10.1038/sj.ki.5001517. View

17.

Chalfant C, Spiegel S . Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J Cell Sci. 2005; 118(Pt 20):4605-12. DOI: 10.1242/jcs.02637. View

18.

Jha J, Banal C, Okabe J, Gray S, Hettige T, Chow B . NADPH Oxidase Nox5 Accelerates Renal Injury in Diabetic Nephropathy. Diabetes. 2017; 66(10):2691-2703. DOI: 10.2337/db16-1585. View

19.

Gooch J, Roberts B, Cobbs S, Tumlin J . Loss of the alpha-isoform of calcineurin is sufficient to induce nephrotoxicity and altered expression of transforming growth factor-beta. Transplantation. 2007; 83(4):439-47. DOI: 10.1097/01.tp.0000251423.78124.51. View

20.

Eberle D, Hegarty B, Bossard P, Ferre P, Foufelle F . SREBP transcription factors: master regulators of lipid homeostasis. Biochimie. 2004; 86(11):839-48. DOI: 10.1016/j.biochi.2004.09.018. View